Plasma Fractionation Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035
Driven by rise in demand for safe and effective medicines, along with increase in rare and chronic disorders, the plasma fractionation market is evolving steadily
Plasma fractionation is a process employed to purify and separate plasma into individual protein components. These fractionates are then purified, which can further be used as therapeutic medicines, known as plasma-derived therapies or plasma-derived medicinal products. This involves a sequence of processes, including precipitation / chromatography, purification, and virus-inactivation. Plasma fractionation is a highly developed bioprocess that can be carried out from small scale to commercial scale production. It is worth highlighting that more than 30 unique therapeutic plasma proteins have already been developed through plasma fractionation which helps to treat various indications.
The global plasma fractionation market valued at $ 5.3 billion in 2025, is projected to reach $ 5.8 billion in 2026 and $ 12.7 billion by 2035, representing a higher CAGR of 9.1% during the forecast period 2026 to 2035.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/plasma-fractionation-market.html
Plasma Fractionation Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035
Driven by rise in demand for safe and effective medicines, along with increase in rare and chronic disorders, the plasma fractionation market is evolving steadily
Plasma fractionation is a process employed to purify and separate plasma into individual protein components. These fractionates are then purified, which can further be used as therapeutic medicines, known as plasma-derived therapies or plasma-derived medicinal products. This involves a sequence of processes, including precipitation / chromatography, purification, and virus-inactivation. Plasma fractionation is a highly developed bioprocess that can be carried out from small scale to commercial scale production. It is worth highlighting that more than 30 unique therapeutic plasma proteins have already been developed through plasma fractionation which helps to treat various indications.
The global plasma fractionation market valued at $ 5.3 billion in 2025, is projected to reach $ 5.8 billion in 2026 and $ 12.7 billion by 2035, representing a higher CAGR of 9.1% during the forecast period 2026 to 2035.
To view more details on this report, click on the link https://www.rootsanalysis.com/reports/plasma-fractionation-market.html